Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug Medical Dialogues Bureau6 Nov 2019 5:02 AM GMTZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial Medical Dialogues Bureau3 Nov 2019 3:30 AM GMTBristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
GSK ovarian cancer drug Zejula gets USFDA nod for wider use Medical Dialogues Bureau24 Oct 2019 4:30 AM GMTZejula was the lead compound of U.S. cancer specialist Tesaro, which GSK acquired for $5.1 billion last year. Zejula brought in sales of 57 million...
Bristol-Myers blockbuster Opdivo fails to meet goal of brain tumour study Medical Dialogues Bureau8 Sep 2019 3:45 AM GMTThe drug, Opdivo, when used along with the current standard of care for glioblastoma multiforme, did not prevent cancer from spreading when compared...
Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 4:00 AM GMTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel Medical Dialogues Bureau28 July 2019 3:47 AM GMTSales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer Medical Dialogues Bureau12 Jun 2019 4:20 AM GMTThe approval is based on results from a late-stage trial, where Keytruda showed a significant improvement in overall survival in cancer patients,...
Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit Medical Dialogues Bureau12 Jun 2019 4:00 AM GMTRoche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
Roche gets USFDA nod for combo lymphoma treatment Polivy Medical Dialogues Bureau11 Jun 2019 4:00 AM GMTPolivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine Farhat Nasim22 May 2019 4:15 AM GMTAzacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
Roche gets USFDA nod for combo drug Venclexta, Gazyva to treat lymphocytic leukaemia Medical Dialogues Bureau17 May 2019 3:45 AM GMT"Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer without...
Pfizer gets CHMP opinion for Talzenna for patients with metastatic breast cancer Farhat Nasim29 April 2019 4:05 AM GMTThe positive CHMP opinion of TALZENNA follows the medicine's approval by the U.S. Food and Drug Administration (FDA) in October 2018.New Delhi:...
